Cargando…

SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity

The causative agent of the COVID-19 pandemic, SARS-CoV-2, is steadily mutating during continuous transmission among humans. Such mutations can occur in the spike (S) protein that binds to the ACE2 receptor and is cleaved by TMPRSS2. However, whether S mutations affect SARS-CoV-2 cell entry remains u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ozono, Seiya, Zhang, Yanzhao, Ode, Hirotaka, Sano, Kaori, Tan, Toong Seng, Imai, Kazuo, Miyoshi, Kazuyasu, Kishigami, Satoshi, Ueno, Takamasa, Iwatani, Yasumasa, Suzuki, Tadaki, Tokunaga, Kenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870668/ https://www.ncbi.nlm.nih.gov/pubmed/33558493 http://dx.doi.org/10.1038/s41467-021-21118-2

Ejemplares similares

MARCH8 inhibits viral infection by two different mechanisms
por: Zhang, Yanzhao, et al.
Publicado: (2020)

Dissecting Naturally Arising Amino Acid Substitutions at Position L452 of SARS-CoV-2 Spike
por: Tan, Toong Seng, et al.
Publicado: (2022)

CRISPR-mediated activation of endogenous BST-2/tetherin expression inhibits wild-type HIV-1 production
por: Zhang, Yanzhao, et al.
Publicado: (2019)

MARCH8 Targets Cytoplasmic Lysine Residues of Various Viral Envelope Glycoproteins
por: Zhang, Yanzhao, et al.
Publicado: (2022)

Phenotypic and Genotypic Co-receptor Tropism Testing in HIV-1 Epidemic Region of Tanzania Where Multiple Non-B Subtypes Co-circulate
por: Judicate, George P., et al.
Publicado: (2021)

Structural Features of Antiviral APOBEC3 Proteins are Linked to Their Functional Activities
por: Kitamura, Shingo, et al.
Publicado: (2011)

The 4th and 112th Residues of Viral Capsid Cooperatively Modulate Capsid-CPSF6 Interactions of HIV-1
por: Saito, Akatsuki, et al.
Publicado: (2020)

Quasispecies Analyses of the HIV-1 Near-full-length Genome With Illumina MiSeq
por: Ode, Hirotaka, et al.
Publicado: (2015)

Cellular APOBEC3A deaminase drives mutations in the SARS-CoV-2 genome
por: Nakata, Yoshihiro, et al.
Publicado: (2023)

Production of HIV-1 vif mRNA Is Modulated by Natural Nucleotide Variations and SLSA1 RNA Structure in SA1D2prox Genomic Region
por: Nomaguchi, Masako, et al.
Publicado: (2017)

SARS-CoV-2 accessory protein ORF8 is secreted extracellularly as a glycoprotein homodimer
por: Matsuoka, Kazuhiro, et al.
Publicado: (2022)

The D614G mutation in the SARS-CoV2 Spike protein increases infectivity in an ACE2 receptor dependent manner.
por: Ogawa, Junko, et al.
Publicado: (2020)

Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation
por: Huang, Szu-Wei, et al.
Publicado: (2020)

Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster
por: Brustolin, Marco, et al.
Publicado: (2021)

Structural basis of chimpanzee APOBEC3H dimerization stabilized by double-stranded RNA
por: Matsuoka, Tatsuya, et al.
Publicado: (2018)

Stability of SARS-CoV-2 Spike G614 Variant Surpasses That of the D614 Variant after Cold Storage
por: Huang, Sheng-Yu, et al.
Publicado: (2021)

Multiple Pathways To Avoid Beta Interferon Sensitivity of HIV-1 by Mutations in Capsid
por: Sultana, Tahmina, et al.
Publicado: (2019)

Cloaking the ACE2 receptor with salivary cationic proteins inhibits SARS-CoV-2 entry
por: Yoshizato, Katsutoshi, et al.
Publicado: (2022)

614. Evaluating the Use of Dalbavancin for Off-Label Indications
por: Taylor, Katherine, et al.
Publicado: (2021)

The G614 pandemic SARS-CoV-2 variant is not more pathogenic than the original D614 form in adult Syrian hamsters
por: Stauft, Charles B., et al.
Publicado: (2021)

Impaired ability of Nef to counteract SERINC5 is associated with reduced plasma viremia in HIV-infected individuals
por: Toyoda, Mako, et al.
Publicado: (2020)

Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor
por: Han, Dong P., et al.
Publicado: (2006)

Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody
por: Valenzuela Nieto, Guillermo, et al.
Publicado: (2021)

Compound heterozygous TYK2 mutations underlie primary immunodeficiency with T-cell lymphopenia
por: Nemoto, Michiko, et al.
Publicado: (2018)

Nanopore Sequencing for Characterization of HIV-1 Recombinant Forms
por: Mori, Mikiko, et al.
Publicado: (2022)

Protease inhibitor Camostat Mesyalte blocks wild type SARS-CoV-2 and D614G viral entry in human engineered miniature lungs
por: Wu, Tong, et al.
Publicado: (2022)

The Identification of a Small Molecule Compound That Reduces HIV-1 Nef-Mediated Viral Infectivity Enhancement
por: Chutiwitoonchai, Nopporn, et al.
Publicado: (2011)

Unique Flap Conformation in an HIV-1 Protease with High-Level Darunavir Resistance
por: Nakashima, Masaaki, et al.
Publicado: (2016)

ACE2: The Major Cell Entry Receptor for SARS-CoV-2
por: Scialo, Filippo, et al.
Publicado: (2020)

Cold atmospheric plasma for preventing infection of viruses that use ACE2 for entry
por: Wang, Peiyu, et al.
Publicado: (2022)

SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2
por: Fenizia, Claudio, et al.
Publicado: (2021)

SARS-CoV-2 cell entry beyond the ACE2 receptor
por: Alipoor, Shamila D., et al.
Publicado: (2022)

ACE2-Independent Bat Sarbecovirus Entry and Replication in Human and Bat Cells
por: Guo, Hua, et al.
Publicado: (2022)

APOBEC3G-Mediated G-to-A Hypermutation of the HIV-1 Genome: The Missing Link in Antiviral Molecular Mechanisms
por: Okada, Ayaka, et al.
Publicado: (2016)

SARS-CoV-2 D614G Variant Exhibits Enhanced Replication ex vivo and Earlier Transmission in vivo
por: Hou, Yixuan J., et al.
Publicado: (2020)

D614G and SARS-CoV-2 replication fitness
por: Engelman, Kathleen D., et al.
Publicado: (2021)

miR614 Expression Enhances Breast Cancer Cell Motility
por: Dang, Tuyen T., et al.
Publicado: (2020)

SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo
por: Hou, Yixuan J., et al.
Publicado: (2020)

Impact of long-term antiretroviral therapy on gut and oral microbiotas in HIV-1-infected patients
por: Imahashi, Mayumi, et al.
Publicado: (2021)

Molecular epidemiological features of SARS-CoV-2 in Japan, 2020–1
por: Ode, Hirotaka, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g31lo05pvvntmivam16gq9r7pe